Advertisement
Loading...

Cannara Biotech Inc.

LOVFFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.23
$-0.01(-0.81%)
U.S. Market is Open • 13:25
Advertisement

Cannara Biotech Inc. (LOVFF) Stock Competitors & Peer Comparison

See (LOVFF) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LOVFF$1.23-0.81%123.5M15.63$0.08N/A
MKGAF$156.98+3.19%67.7B22.97$6.78+1.65%
MKKGY$30.72+2.16%65.9B22.13$1.37+1.70%
IPSEY$46.60-0.72%61.6B30.26$1.54+0.86%
TKPHF$32.10-1.53%50.7B42.80$0.75+4.06%
HLNCF$4.73+2.38%42.5B19.20$0.25+1.99%
SDZNY$84.12+2.60%36B39.80$2.09+1.23%
TEVJF$30.19+0.00%35.2B24.95$1.21N/A
TAIPY$14.00+16.67%18.1B82.35$0.17N/A
ESALY$61.51-2.11%17.6B20.54$3.00N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LOVFF vs MKGAF Comparison May 2026

LOVFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LOVFF stands at 123.5M. In comparison, MKGAF has a market cap of 67.7B. Regarding current trading prices, LOVFF is priced at $1.23, while MKGAF trades at $156.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LOVFF currently has a P/E ratio of 15.63, whereas MKGAF's P/E ratio is 22.97. In terms of profitability, LOVFF's ROE is +0.09%, compared to MKGAF's ROE of +0.08%. Regarding short-term risk, LOVFF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for LOVFF.Check MKGAF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions